Background Large-scale prospective data are needed to determine whether associations
between lipoprotein (a)(Lp [a]) and coronary heart disease (CHD) risk are independent of …

Background—Studies of the association between the plasma concentration of lipoprotein
(a)[Lp (a)] and coronary heart disease (CHD) have reported apparently conflicting findings …

Objectives: The purpose of this study was to assess the prognostic utility of lipoprotein (a)[Lp
(a)] in individuals with coronary artery disease (CAD). Background: Data regarding an …

Objective.—To examine the relationship between elevated levels of lipoprotein (a)[Lp (a)]
and coronary heart disease (CHD) risk in a prospective study. Design.—Nested case-control …

Objective.—To assess prospectively the risk of myocardial infarction (Ml) associated with
elevated levels of lipoprotein (a)(Lp [a]). Design.—Nested case-control study using …

The association of an elevated level of lipoprotein (a)(Lp (a)) with the development of
coronary heart disease (CHD) remains controversial. Lp (a) was investigated as a CHD risk …

Abstract Background: Increased lipoprotein (a)[Lp (a)] concentrations are predictive for
coronary artery disease (CAD). The risk conferred by Lp (a) for other types of vascular …

Aims As promising compounds to lower Lipoprotein (a)(Lp (a)) are emerging, the need for a
precise characterization and comparability of the Lp (a)-associated cardiovascular risk is …

Abstract Background: Lipoprotein (a)[Lp (a)] is a causal risk factor for cardiovascular
diseases that has no established therapy. The attribute of Lp (a) that affects cardiovascular …

Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular
Mortality - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …